AI assistant
Sending…
Editas Medicine, Inc. — Director's Dealing 2016
Feb 3, 2016
33260_dirs_2016-02-02_27ce8ec4-3cd6-406b-adb7-7d6df751e55e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2016-02-02
Reporting Person: Liu David R. (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 480769 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $6.48 | 2025-09-13 | Common Stock (96153) | Direct |
Footnotes
F1: These shares are restricted stock owned by David Liu and issued pursuant to a restricted stock agreement between the Issuer and Mr. Liu. Twenty-five percent of the shares vested on November 21, 2013, and the remainder are scheduled to vest in equal monthly installments from August 1, 2013 until August 1, 2017.
F2: This option was granted on September 14, 2015 and is scheduled to vest over four years with the shares scheduled to vest in equal quarterly installments beginning on December 10, 2015.
More from Editas Medicine, Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 27